What analysts think of Novo, Him & Hers after obesity pill withdrawal

Novo Nordisk's Denmark-listed shares climbed more than 7%, while the stock gained close to 6% in US premarket trading after telehealth company Hims & Hers said it would stop offering its newly launche... ...